Search Results
Jun 07, 2026, 21:00 ET Uhale Adopts Quokka's Q-mast to Strengthen Application Security Testing
vulnerabilities, privacy risks, and compliance gaps earlier in the development process."Security is a continuous process," said Lewis Zhang, R&D General Manager at Uhale. "Adding Q-mast to our workflow is a practical step to strengthen our testing capabilities. It gives us additional visibility as we
More news about: Uhale
Jun 07, 2026, 21:00 ET GIGABYTE impulsa las tecnologías de monitores gaming con imágenes optimizadas por IA y protección OLED automática
/PRNewswire/ -- GIGABYTE, la marca líder mundial en informática, sigue avanzando en sus tecnologías de monitores gaming a través de imágenes optimizadas por IA y protección OLED inteligente. A medida que las pantallas gaming evolucionan más allá de las especificaciones de panel tradicionales, la serie AORUS
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE impulsa las tecnologías de los monitores para juegos con imágenes optimizadas mediante IA y protección automática de OLED
verde, para garantizar una visibilidad óptima ante cualquier cambio de fondo. Junto a funciones ya conocidas como Tactical Switch 2.0, Ultra Clear, Night Vision, Black Equalizer y Game Assist, estas novedades ofrecen a los jugadores mayor visibilidad, conciencia situacional y control total durante la
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE Advances Gaming Monitor Technologies with AI-optimized Visuals and Automatic OLED Protection
OLED CARE PRO is an enhanced thermal design featuring integrated heat pipes and advanced thermal materials. The FO27Q28G delivers a 12% reduction in T-Con temperature, a 5% lower peak surface temperature, and up to 35% better temperature uniformity compared to competing flagship models. Selected models,
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE Advances Gaming Monitor Technologies with AI-optimized Visuals and Automatic OLED Protection
OLED CARE PRO is an enhanced thermal design featuring integrated heat pipes and advanced thermal materials. The FO27Q28G delivers a 12% reduction in T-Con temperature, a 5% lower peak surface temperature, and up to 35% better temperature uniformity compared to competing flagship models. Selected models,
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET 노보네시스, 서울푸드 2026에서 한국 식품업체를 위한 바이오솔루션 선보여
multimedia:https://www.prnewswire.com/kr/news-releases/uB178uBCF4uB124uC2DCuC2A4u002Cu002DuC11CuC6B8uD478uB4DCu002Du0032u0030u0032u0036uC5D0uC11Cu002DuD55CuAD6Du002DuC2DDuD488uC5C5uCCB4uB97Cu002D-302789885.htmlSOURCE
More news about: Novonesis
Jun 07, 2026, 20:53 ET Sungrow Perluas Portofolio Sistem Penyimpanan Energi Residensial dengan Solusi Generasi Baru untuk Cadangan Daya yang Andal
160%. Kemampuan tersebut membantu pengguna memanfaatkan lebih banyak energi surya sepanjang hari. Dengan dukungan arus masukan hingga 20A, solusi ini kompatibel dengan sebagian besar panel PV utama di pasar sehingga semakin fleksibel untuk instalasi baru dan proyek retrofit. Selain mampu
More news about: Sungrow
Jun 07, 2026, 20:53 ET Sungrow mở rộng danh mục hệ thống lưu trữ năng lượng (ESS) dân dụng với giải pháp thế hệ mới đảm bảo nguồn điện dự phòng đáng tin cậy
đạt 160%, giúp các hộ gia đình khai thác được nhiều năng lượng mặt trời hơn trong suốt cả ngày. Với khả năng hỗ trợ dòng điện đầu vào lên tới 20A, giải pháp tương thích với hầu hết các mô-đun quang điện phổ biến trên thị trường, mang lại sự linh hoạt cao hơn cho cả các dự án lắp đặt mới lẫn dự
More news about: Sungrow
Jun 07, 2026, 20:10 ET Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously
More news about: Ascletis Pharma Inc.
Jun 07, 2026, 20:08 ET OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
the world to enter a confirmatory trial, and the first CAR-T product for a liver cancer indication to reach a Phase II randomised controlled study — a milestone that underscores China's potential to lead the next wave of innovation in cell therapy for solid tumours.HCC, a disease with few options
More news about: Oricell Therapeutics Holdings Limited
Jun 07, 2026, 20:00 ET UPST Deadline: UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit
[email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 8, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 20:00 ET Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
changes in pathways associated with T cell signaling and immune regulation. In vivo, a mouse surrogate of ATG-207 demonstrated therapeutic activity in both experimental autoimmune encephalomyelitis, a multiple sclerosis model, and adoptive T cell transfer colitis, an inflammatory bowel disease
More news about: Antengene Corporation Limited
Jun 07, 2026, 19:05 ET El décimo "67 Brand Customer Day" de Dongfeng Liuzhou Motor avanza en nuevas vías para el crecimiento global
empoderar a las conductoras de camiones en la industria del transporte de mercancías. Mientras tanto, la empresa continúa apoyando las iniciativas de educación profesional y bienestar público en el extranjero al operar el proyecto Luban Workshop en Laos, que brinda oportunidades de empleo a muchos
More news about: Dongfeng Liuzhou Motor Co., Ltd.
Jun 07, 2026, 18:54 ET Bitmine Immersion Technologies 宣佈增額 A 系列永續優先股招股定價
系列優先股。 因行使清購權或發生稅務事件而贖回的任何 A 系列優先股，其贖回價格為一筆現金金額，相等於截至公司發出相關贖回通知日前一個營業日為止，待贖回的 A 系列優先股之清盤優先權，再加上截至贖回日（但不包括該日）的累計及未付定期股息。若然發生構成規管 A 系列優先股的指定證書中所定義的「基本變化」事件，A 系列優先股的持有人將有權要求公司以現金回購價格，回購其所持有的部分或全部 A 系列優先股股份；該回購價格相等於待回購的 A 系列優先股的設定金額，再加上截至基本變化回購日（但不包括該日）的累計及未付定期股息（如有）。A 系列優先股的清盤優先權最初為每股 100 美元。
More news about: Bitmine Immersion Technologies, Inc.
Jun 07, 2026, 18:52 ET Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
22.6%, from a close of $16.84 per share on April 21, 2026, to close at $13.04 per share on April 22, 2026.WHAT SRAD INVESTORS CAN DO NOW:File to be lead plaintiff by July 17, 2026.Contact KTMC for a free case evaluation. All representation is on a contingency
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 07, 2026, 18:30 ET VolitionRx Announces Pricing of $4.6 Million Public Offering
means of a prospectus. A preliminary prospectus supplement and the accompanying base prospectus relating to and describing the terms of the public offering were filed with the SEC and are available on the SEC's website at www.sec.gov. A final
More news about: VolitionRx Limited
Jun 07, 2026, 18:13 ET FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit
[email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
being investigated by Novo Nordisk as a treatment for adults with overweight or obesity (REDEFINE program) and as a treatment for adults with type 2 diabetes (REIMAGINE program). CagriSema is a fixed-dose combination of a long-acting amylin analog, cagrilintide, and a GLP-1 receptor agonist,
More news about: NOVO NORDISK INC.
Jun 07, 2026, 17:30 ET Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
REIMAGINE 1 trial is a phase 3, randomized, double-blind study evaluating the safety and efficacy of CagriSema in adults with type 2 diabetes who have not responded to diet or exercise, compared to a placebo. The treatment was given as a once-weekly injection for nine months, followed by a period without treatment
More news about: American Diabetes Association
Jun 07, 2026, 17:13 ET Quantinuum 宣布其增額首次公開招股已完成交割
/美通社/ -- Quantinuum Inc. (Nasdaq: QNT) (「Quantinuum」) 今日宣布，其增額首次公開招股已完成交割，定價為每股 60.00 美元，向公眾發售 28,000,000 股 A 類普通股。 所有股份均由 Quantinuum 發售。 是次發售在未扣除承銷折扣、佣金及其他招股開支前，所得款項總額為 16.8 億美元。 Quantinuum 的 A 類普通股以「QNT」為交易代號，於納斯達克全球市場 (Nasdaq Global Market) 掛牌。
More news about: Quantinuum
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
more than 50%, down to 45 mg/dL. After a median follow-up of 4.6 years, there was a 29% reduction in 3-P MACE in patients with high-risk diabetes treated with evolocumab, compared to the placebo group. The use of evolocumab decreased 4-P MACE by 21%. The risk of a heart attack was lowered by 35% and lower
More news about: American Diabetes Association
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
England Journal of Medicine in November 2025. Repatha demonstrated a 25% relative reduction in the risk of a composite of coronary heart disease (CHD) death, heart attack or ischemic stroke (3-P MACE), and 19% reduction in a broader composite that also included any ischemia-driven arterial revascularization
More news about: Amgen
Jun 07, 2026, 16:42 ET Quantinuum anuncia el cierre de su oferta pública inicial ampliada
LLC, 180 Varick Street, 2nd Floor, Nueva York, Nueva York 10014, a la atención de: Prospectus Department o por correo electrónico a [email protected]; Jefferies LLC, a la atención de: Equity Syndicate Prospectus Department, 520 Madison
More news about: Quantinuum
Jun 07, 2026, 16:39 ET Quantinuum anuncia o fechamento de oferta pública inicial ampliada
de tal estado ou jurisdição.Sobre a QuantinuumA Quantinuum é uma empresa líder em computação quântica que oferece uma plataforma completa (full-stack) projetada para tornar a computação quântica aplicável em ambientes do mundo real. A empresa implantou comercialmente múltiplas gerações
More news about: Quantinuum
Jun 07, 2026, 16:04 ET CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN
Tvorcovia mali k dispozícii kulisy vyrobené na mieru, profesionálnych hercov a kaskadérov a mali za úlohu posunúť hranice rozprávania príbehov o starostlivosti o pleť a zároveň vdýchnuť život prípravkom CeraVe na čistenie pleti a inováciám v oblasti opaľovania prostredníctvom štyroch tematických oblastí:
More news about: CeraVe